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Abstract
Intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) are 
continuation of the same pathological and physiological processes that are largely unrec-
ognized in critical patients. From an era of indistinct definitions and recommendations, 
this condition has been studied extensively and experts have come forward with clear 
definitions and recommendations for management. IAH is graded in four grades and 
ACS is IAH above 20 cm H
2
O with new organ dysfunction. IAH/ACS can present as 
acute, hyperacute, or chronic and aetiologically can be classified into primary, secondary 
and tertiary. It affects various body systems including respiratory, cardiovascular, central 
nervous, gastrointestinal, renal and hepatic systems adversely and results in deleteri-
ous consequences. Management of IAH/ACS is based on the evacuation of intra-luminal 
and extra-luminal contents, improving the abdominal wall compliance. There are vari-
ous surgical techniques recommended for preventing the development of IAH/ACS and 
mitigating the negative consequences. New medical therapies such as octreotide, tissue 
plasminogen activator, melatonin and vitamin C are being investigated and non-pharma-
cological methods such as continuous negative abdominal pressure (CNAP) have been 
introduced recently but are still experimental and not recommended for routine use.
Keywords: intra-abdominal hypertension (IAH), abdominal compartment syndrome 
(ACS), open abdomen
1. Introduction
Intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) are 
largely unrecognized conditions but prevalent in ICU patients. It is a continuum of varying 
degree of increase in intra-abdominal pressure (IAP) ranging from IAH to ACS. Most studies 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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evaluating the incidence of ACS have been performed in trauma patients, with estimates of 
incidence varying considerably. While the largest study [1] (n = 706) reported an incidence of 
ACS of 1%, two smaller though observational studies [2, 3] (n = 128 and 188) reported a higher 
incidence of ACS of 9–14%. The incidence of intra-abdominal hypertension (IAH) is not well 
reported in the literature. The wide variation in the reported incidence may be attributed to 
differences in diagnostic criteria employed in studies.
2. Definitions
There was an era of indistinct and variable definitions of IAH/ACS with variable methods 
of measurement of intra-abdominal pressure (IAP) until the World Society of Abdominal 
Compartment Syndrome (WSACS) was formed and they formulated definitions, standard-
ized measurement methodology and provided management guidelines.
Intra-abdominal pressure: Intra-abdominal pressure (IAP) is the steady state pressure concealed 
within the abdominal cavity (Figure 1) [4]. An IAP of 5–7 mmHg is considered normal for 
most critically ill patients. IAP is directly related to body mass index (BMI) [5].
Abdominal perfusion pressure: Abdominal perfusion pressure (APP) is calculated by subtract-
ing IAP from the mean arterial pressure (MAP): APP = MAP − IAP. Elevated intra-abdominal 
pressure reduces blood flow to the abdominal viscera. A target APP of at least 60 mmHg is 
correlated with improved survival among patients with IAH and ACS [6].
Intra-abdominal hypertension: Intra-abdominal hypertension (IAH) is defined as a sustained 
intra-abdominal pressure ≥12 mmHg (Figure 1) [7, 8]. This value was established arbitrarily. 
Intra-abdominal pressure can be further graded as follows:
Grade I = IAP 12–15 mmHg
Grade II = IAP 16–20 mmHg
Grade III = IAP 21–25 mmHg
Grade IV = IAP > 25 mm Hg
Hyper-acute IAH refers to elevation of the intra-abdominal pressure lasting only seconds due 
to any strenuous physical activity, sneezing, coughing, laughing, straining, or defecation, etc.
Acute IAH refers to elevation of the intra-abdominal pressure that develops over hours, 
which occurs usually due to surgical causes. Sub-acute IAH refers to elevation of the intra-
abdominal pressure that develops over days usually due to medical conditions.
Chronic IAH refers to elevation of intra-abdominal pressure that develops over months (preg-
nancy) or years (morbid obesity)]. Chronic elevation of IAP usually does not result in ACS 
unless it is superimposed on acute or sub-acute IAH.
Abdominal compartment syndrome: ACS is defined as a sustained intra-abdominal pressure >20 
mmHg (with or without APP <60 mmHg) that is associated with new organ dysfunction [4, 7, 8].
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ACS can be classified as primary and secondary.
Primary ACS is due to injury or disease in the abdominopelvic region. This could be intra-
luminal or extra-luminal causes. Extra-luminal causes could be any pathology causing intra-
abdominal collections outside the bowel lumens e.g. abdominal trauma, hemoperitoneum and 
pancreatitis. IAH/ACS can also develop due to intra-luminal pathology like intestinal obstruc-
tion, gastroparesis, pseudocolonic obstruction and pseudomembranous colitis (Figure 2), etc.
Secondary ACS refers to conditions that do not originate in the abdomen or pelvis (e.g. fluid 
resuscitation, sepsis, and burns).
Recurrent ACS defines a condition in which ACS develops again following previous surgical 
or medical treatment of primary or secondary ACS [9].
Figure 2. Pseudomembranous colitis due to clostridium difficile causing ACS [49].
Figure 1. Intra-abdominal pressure (from: https://www.slideshare.net/drabdulgafoormt/intraabdominal-hypertension).
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3. Physiological consequences of IAH/ACS
ACS is not just an abdominal condition but rather a systemic problem that has tremendous 
impact on all organ systems including, but not limited to, cardiovascular system, respiratory 
system, central nervous system, renal system and hepatobiliary system.
Cardiovascular system: IAH/ACS results in cephalad movement of diaphragm that in turn can 
cause depression of ventricular compliance and contractility [10]. Another impact of IAH is 
reduced venous return from lower extremities that results in reduced preload and stagnation 
of blood in lower extremities causing deep vein thrombosis (DVT) [11].
Pulmonary system: Increased peak inspiratory and mean airway pressures induced by high 
IAP in mechanically ventilated patients can cause alveolar barotrauma. Associated with 
reduced chest wall compliance and reduced spontaneous tidal volumes, this cause arterial 
hypoxemia and hypercarbia. Pulmonary infection is also more common among patients with 
IAH [12]. According to animal studies, these effects are mediated through compression of the 
lung leading to atelectasis, oedema, increased intrapulmonary shunt fraction, decreased gas 
transfer and increased alveolar dead space [13].
Renal system: Kidney is affected by IAH/ACS by two ways: by direct compression of renal vein 
and by increased renal vasoconstriction caused by renin angiotensin induced by the decrease 
in preload.
The renal filtration gradient (FG) can be considered as the net force across the glomeru-
lus. It is the gradient between the glomerular filtration pressure (GFP) and the proximal 
tubular pressure (PTP). In the presence of IAH, PTP is same as IAP. GFP is equivalent to 
the mean arterial pressure (MAP), and thus GFP can be estimated as MAP minus twice the 
IAP. Thus, the impact of IAP on the renal function and urine production is much greater 
than that caused by changes in MAP. So oliguria manifest is one of the first visible signs 
of IAH [14].








= (MAP − IAP ) − PTP
 
 = (MAP − IAP ) − IAP 
 =  MAP − 2 × IAP
 (1)
Hence, when IAP is doubled, filtration gradient will be decreased by four-folds. Oliguria 
generally develops at an intra-abdominal pressure of approximately 15 mmHg, while anuria 
usually develops at an intra-abdominal pressure of approximately 30 mmHg [15]. Because 
of impairment in renal perfusion, the urine sodium and chloride concentrations are usually 
decreased. Along with increased plasma renin activity, aldosterone concentration and antid-
iuretic hormone concentration are also increased to more than twice their baseline levels, 
which has tremendous impact on the renal function [16].
Intensive Care60
Gastrointestinal system: The gut is very sensitive to increase in IAP as the primary organ is 
exposed to high IAP, which can occur at IAP as low as 10 mmHg [17]. At 20 mmHg of IAP 
mucosal perfusion pressure of the gut is decreased [18] and at 40 mmHg celiac and superior 
mesenteric blood flow are reduced [19]. IAH also impairs venous flow from the intestine by 
compressing intestinal veins and causes intestinal oedema. This increases intra-abdominal 
pressure further, as a vicious cycle [20]. This leads to worsened hypo perfusion, bowel isch-
emia, decreased intra-mucosal pH and lactic acidosis [21]. Hypoperfusion of the gut may 
result in loss of the mucosal barrier, leading to bacterial translocation, sepsis and multiple 
system organ failure. Bacterial translocation has been shown to occur at IAP of only 10 mmHg 
in the presence of haemorrhage [22].
Hepatic: Liver is affected by IAH by reducing its ability to clear lactate even with adequate 
cardiac output and blood pressure and this can occur with IAP as low as 10 mmHg [23].
Central nervous system: The effect of IAH on intracranial pressure (ICP) range from tran-
sient increases during the short-lived elevation of intra-abdominal pressure that occurs with 
coughing, defecating or emesis to sustained elevation during persistent elevation of IAH. 
This can lead to a critical decrease in cerebral perfusion pressure (CPP) [24]. Decompressive 
laparotomy was found to decrease ICP drastically in a case of ACS as reported by Bloomfield 
et al. [25].
4. Diagnosis
Physical examination was found to be neither sensitive nor specific for the diagnosis of IAH/
ACS with a sensitivity of 56%, specificity of 87%, positive predictive value of 35%, negative 
predictive value of 94% and accuracy of 84% [26]. Imaging studies such as chest X-ray, ultra-
sound abdomen and CT scan are not useful to diagnose IAH/ACS efficiently but can give 
some clue to the possibility, such as elevated diaphragm, basal atelectasis, inferior venae caval 
compression, tense infiltration of the retro peritoneum that is out of proportion to peritoneal 
disease, massive abdominal distension, direct renal compression or displacement, bowel wall 
thickening or bilateral inguinal herniation [27].
Various techniques have been described for IAP measurement using intra-vesical, intra-
gastric or inferior venae caval catheters. WSACS has standardized intra-vesical (urinary 
bladder) pressure measurement as the gold standard for measurement of IAH/ACS [28]. 
This was done through puncturing the aspiration port of Folley’s catheter or attaching a 
three-way stopcock and connecting it to a manometer, but nowadays a closed system has 
been developed which avoids the puncturing and ensures sterility (Figure 3). The pressure 
is measured at end-expiration in the supine position after ensuring that abdominal muscle 
contractions are absent. The transducer should be zeroed at the level of the mid-axillary line. 
WSACS has also standardized the amount of saline to be instilled as up to 25 ml. However, as 
a downside, the bladder pressure may be inaccurate in the presence of intra-peritoneal adhe-
sions, pelvic hematomas, pelvic fractures, abdominal packs or a neurogenic bladder [29].
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5. Management of IAH/ACS
Surgical decompression is the definitive management of IAH/ACS but supportive medical 
therapy should be attempted before resorting to this. WSACS has provided algorithm for 
management of IAH/ACS (Algorithms 1 and 2). Nowadays, the trend is more towards less 
invasive management such as abdominal wall escharotomy in burns [30] or percutaneous 
drainage of intra-abdominal collections [31].
Principles of supportive care are [32] as follows:
1. Evacuate intra-luminal contents: nasogastric and rectal drainage.
2. Drain extra-luminal collections: evacuate hemoperitoneum, ascites, intra-abdominal abscess 
and retroperitoneal hematoma.
3. Improve abdominal wall compliance: supine position, adequate analgesia, sedation and some-
times muscle paralysis.
Many of IAH/ACS patients will need ventilatory support and should have a lung protective 
strategy like low tidal volume, pressure limitation, permissive hypercapnea, use of positive 
end expiratory pressure (PEEP) and use of muscle relaxants in indicated patients.
Aggressive fluid resuscitation is one of the risk factors for the development of ACS. As these 
patients are haemodynamically unstable initially, they receive large amounts of crystalloids 
with resultant bowel oedema and development or aggravation of ACS. Liberal use of colloids 
Figure 3. Closed system for intra-abdominal pressure monitoring (adapted from: Roberto et al. [50]).
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has not yet proved to prevent this. But on the other side optimum fluid resuscitation can pre-
vent some negative aspects of ACS such as reduced cardiac output, renal blood flow, urine 
output and visceral perfusion.
Decompressive laparotomy is the definitive treatment for ACS. Many surgeons resort to decom-
pression when the IAP is above 25, but a lower threshold would be better in terms of organ 
saving. An approach based on abdominal perfusion pressure (APP) rather than IAP would 
be more logical, and a threshold APP of 50 mmHg was found to correlate with mortality [33]. 
Algorithm 1. Management of IAH/ACS by WSACS: Adapted from World Society of the Abdominal Compartment Syndrome 
(WSACS) website: http://www.wsacs.org.
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An open abdomen approach after decompression with temporary closure methods is com-
monly used by most surgeons to prevent recurrent ACS.
There are different methods for managing open abdomen (OA). Abdomen can be closed with 
temporary abdominal closure using various techniques, which should be later followed by inter-
val abdominal closure, by bringing the edges of the abdominal fascia together primarily ( primary 
closure) if possible technically. If technically not feasible, OA can be closed either using a func-
tional closure or simple coverage [34]. Negative pressure techniques like vacuum-assisted clo-
sure (VAC) (Figure 4), patch technique (e.g. Whittmann patch, polytetrafluoroethylene patch), 
Algorithm 2.  Medical management of IAH/ACS by WSACS: Adapted from World Society of the Abdominal Compartment 
Syndrome (WSACS) website: http://www.wsacs.org.
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silo technique (e.g. Bagota bag) (Figure 5) and skin-only technique using towel clips are some 
methods used in the management of open abdomen. Each technique has its own advantages and 
disadvantages and description of that is beyond the scope of this chapter.
Closure of abdomen after the ACS also utilizes different methods such as STAR (staged 
abdominal repair), component separation and planned ventral hernia. An international con-
sensus conference on open abdomen in Trauma [35] concluded that open abdomen (OA) in 
trauma is advisable at the end of damage-control laparotomy, especially in the presence of 
swelling of viscera, for a second look if there are vascular injuries or gross contamination of 
Figure 4. Vacuum-assisted closure (from: https://www.slideshare.net/drabdulgafoormt/intraabdominal-hypertension).
Figure 5. Bagota bag closure (from Huang et al. [51]).
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the peritoneal cavity, or if there is loss of abdominal wall, and in cases of failure of medical 
treatment of abdominal compartment syndrome, but early closure is mandatory to prevent 
complications such as fistulae formation and frozen abdomen. A review by Sugrue M, opined 
that the key to optimizing outcome in ACS is early abdominal closure within 7 days because 
failure to do so increases morbidity, mortality and fistulae formation [36].
6. Recent insights
In a recent experimental study, Leng et al. [37] indicated that mitochondrial Ca2+uptake 1 
(MICU1)-related oxidation/antioxidation disequilibrium is strongly involved in IAH-induced 
damage to intestinal barriers. MICU1-targeted treatment may hold promise for preventing 
the progression of IAH to gut-derived sepsis. Earlier in 2014, an animal study led by the 
same author found that acute exposure to slightly elevated IAP may result in adverse effects 
on intestinal permeability and the pro-oxidant-antioxidant balance and so monitoring IAP 
is very important in critical patients [38]. In another experiment in rats by Liu et al. [39], 
Melanocortin 4 (MC4 receptor) agonist counteracts the intestinal inflammatory response, 
ameliorating intestinal injury in experimental secondary IAH by MC4 receptor-triggered acti-
vation of the cholinergic anti-inflammatory pathway. This may represent a promising strat-
egy for the treatment of IAH in the future.
A systematic review and individual patient data meta-analysis on intra-abdominal hyperten-
sion in critically ill patients: the wake-up project (World initiative on Abdominal Hypertension 
Epidemiology, a Unifying Project) [40] in 2014 looking at the outcome and mortality in IAH/
ACS found that the only independent predictors for IAH were SOFA score and fluid balance 
on the day of admission. 513 patients out of 2707 patients (30.8%) died in ICU. The indepen-
dent predictors for intensive care mortality were SAPS II score, IAH, SOFA score and admis-
sion category. This review showed that IAH is an independent predictor for mortality and is 
frequently present in critically ill patients more than anticipated.
New medical treatment options that are still experimental include tissue plasminogen activa-
tor (tPa), theophylline and octreotide. tPa was evaluated for retroperitoneal hematoma by 
Horer et al. [41]. They analysed 13 patients who developed ACS with multiple organ failure in 
the ICU. The mean IAP was 23.5 mmHg before decompression (range 12−35), and when tPA 
was given, IAP dropped to a mean of 16 mmHg (range 10−28.5) after 24 h of administration. 
Drainage of hematoma after tPa increased to 1520 mL (range 170−2900) from 370 mL (range 
5−1000). This also coincided with improvement in urinary output and haemodynamics.
Bodnar et al. [42] found a positive correlation between IAH and increased levels of serum ade-
nosine and interleukin10 concentrations in 45 surgical patients with IAP >12 mmHg. Based 
on these findings, they conducted another study [43] comparing standard medical treatment 
in patients with IAH versus standard medical treatment and theophylline infusions twice 
daily. Mortality in theophylline group was 0% when compared to standard group (55%). 
Theophylline improved renal function, splanchnic perfusion, and cardiac contractility pos-
sibly by counteracting adenosine binding to adenosine receptors. The authors postulated that 
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by decreasing circulating adenosine concentrations, theophylline infusion improves IAH-
related mortality in surgical patients
Octreotide, a synthetic somatostatin analogue, by decreasing myeloperoxidase (MPO) activ-
ity and malondialdehyde levels and thereby increasing levels of glutathione if given before 
decompression of IAP has been shown to improve the reperfusion-induced oxidative damage 
in rats with ACS [44]. This translates to that octreotide might have a therapeutic role as an 
agent limiting reperfusion injury among patients with IAH and ACS.
Free radical scavengers such as melatonin and vitamin C (ascorbic acid) were also tried in the 
medical management of IAH/ACS and found useful in animal studies [45]. Vitamin C was 
found to reduce resuscitation fluid requirements significantly thereby preventing secondary 
ACS and IAH in burns [46].
Another nonsurgical technique being investigated is continuous negative extra-abdominal 
pressure (CNAP). Bloomfield et al. [47] demonstrated a significant reduction in IAP when con-
tinuous negative pressure was applied by vacuum via a large poncho into which the entire ani-
mal was placed. There was a mean reduction in IAP from 30.7 ± 1.3 to 18.2 ± 1.3 mmHg. Apart 
from IAP, central venous pressure (CVP), inferior venae caval (IVC) pressure, intra cranial 
pressure (ICP), pulmonary artery occlusion pressure (PAOP) and peak airway pressure were 
also reduced. This was also evaluated in a human study by Sugerman et al. [48], which proved 
the above benefits although some patients expressed discomfort in lower chest and pelvic 
area. All the novel medical options for management of IAH/ACS apart from standard medical 
management-like evacuation of intra and extra luminal contents, improvement of abdominal 
wall compliance, are still in experimental stage and not recommended for routine use.
7. Conclusion
IAH/ACS is not a problem limited to the abdomen but rather a systemic problem affecting 
various body systems adversely with deleterious consequences. Addressing this impor-
tant pathology in a timely manner is crucial for the better outcome of critically ill patients. 
Mainstay of the management in IAH/ACS is still surgical decompression but medical options 
are equally important interventions. Novel therapies in medical options are being explored 
and needs further validation to be recommended in routine management of patients with 
intra-abdominal hypertension and abdominal compartment syndrome.
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